SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-229437
Filing Date
2021-07-30
Accepted
2021-07-29 17:32:25
Documents
3
Period of Report
2021-07-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d203496d8k.htm 8-K 21561
2 EX-3.1 d203496dex31.htm EX-3.1 27091
3 EX-3.2 d203496dex32.htm EX-3.2 100125
  Complete submission text file 0001193125-21-229437.txt   150226
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40629 | Film No.: 211128822
SIC: 2836 Biological Products, (No Diagnostic Substances)